Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea

• Status: Withdrawn
• Trial end date: 2019-01-02
• Target enrollment: 0
• Participant gender: All

Summary

This is an interventional and prospective study. The study is designed to evaluate the additional benefits of a combination of IPL treatment and local application of Bromonide 0.33% gel in the treatment of erythematotelangiectatic (ETR) and papulopustular (PPR).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rabin Medical Center

Criteria

Inclusion Criteria:

• patient (male or female) must be over 18 yaers old of age and fulfil one of the following:

1. Suffer from ETR

2. Suffer from PPR

3. Suffer from a combination of ETR and PPR.

Exclusion Criteria:

• 1.Under 18 years old of age. 2.Pregnant women. 3.Systemic treatment of rosacea at the previous six months before enrollment. 4.Topical treatment of rosacea at the previous one month before enrollment. 5.Phymatous or occular rosacae.